Fulgent Genetics, Inc. Common Stock (FLGT) is a publicly traded Healthcare sector company. As of October 15, 2026, FLGT trades at $21.28 with a market cap of $578.10M and a P/E ratio of 0.00. FLGT moved +1.38% today. Year to date, FLGT is -16.61%; over the trailing twelve months it is -6.24%. Its 52-week range spans $13.46 to $31.04. Analyst consensus is neutral with an average price target of $19.00. Rallies surfaces FLGT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
FLGT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. FLGT recently traded at $21.28. Market cap is $578.10M. P/E ratio is 0.00. Revenue is $323.93M.
| Metric | Value |
|---|---|
| Price | $21.28 |
| Market Cap | $578.10M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.04 |
| 52-Week Low | $13.46 |
| Volume | 41.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $323.93M |
| Net Income | $-85.47M |
| Gross Margin | 35.58% |
1 analysts cover FLGT: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $19.00.